April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Nicardipine hydrochloride injection, American Regent<br />
2.5 mg/mL, 10 mL vials (NDC 40042-0047-10)<br />
Reason for the Shortage<br />
• Teva recalled 4 lots nicardipine injection because the product did not meet purity specifications.<br />
The recalled lots are 31302508B, 31302510B, 31302957B, 31303195B.<br />
• Teva discontinued nicardipine injection in September, 2010.<br />
• American Regent had temporarily suspended distribution of all drug products in <strong>April</strong>, 2011.<br />
• American Regent resumed manufacturing in Shirely, New York in early-May, 2011.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=31<br />
Source: www.ashp.org<br />
Nalbuphine Injection<br />
March 29, <strong>2012</strong><br />
Products Affected - Description<br />
Nalbuphine injection, Hospira<br />
10 mg/mL 1 mL ampules (NDC 00409-1463-01)<br />
10 mg/mL, 1 mL Novaplus ampule (NDC 00409-1463-49)<br />
20 mg/mL 1 mL ampules (NDC 00409-1465-01)<br />
20 mg/mL, 1mL Novaplus ampule (NDC 00409-1465-49)<br />
Reason for the Shortage<br />
• Endo discontinued Nubain in 2008.<br />
• Teva discontinued all nalbuphine injections in July, 2010.<br />
• Hospira has nalbuphine on shortage due to manufacturing delays.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=665<br />
Source: www.ashp.org<br />
Metoclopramide Injection<br />
March 29, <strong>2012</strong><br />
Products Affected - Description<br />
Metoclopramide injection, Hospira<br />
5 mg/mL, 2 mL vials (NDC 00409-341401)<br />
Reason for the Shortage<br />
• Baxter had metoclopramide injection on back order due to regulatory issues. Baxter sold some<br />
generic injectable products to West-Ward. West-Ward then discontinued the metoclopramide<br />
injection in January, <strong>2012</strong>.<br />
• Teva discontinued metoclopramide injection in February, 2011.<br />
• Hospira discontinued metoclopramide ampules in February, 2010, and Carpuject syringes in May,<br />
2009. Hospira is the only manufacturer of metoclopramide injection.<br />
Article Link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=611<br />
Source: www.ashp.org<br />
Diphenhydramine Hydrochloride for Injection<br />
March 29, <strong>2012</strong><br />
Products Affected - Description<br />
Diphenhydramine injection, 50 mg/mL, Hospira<br />
1 mL Carpuject syringe (NDC 00409-2290-31)<br />
Diphenhydramine injection, 50 mg/mL, Mylan Institutional<br />
10 mL vial (NDC 67457-0124-10)<br />
73